BC005561 Inhibitors

Chemical inhibitors of THO complex subunit 2-like can interfere with its function in various ways, primarily by impeding processes upstream of mRNA processing. Aphidicolin, for example, inhibits DNA polymerases alpha and delta, which are pivotal for DNA replication. Since THO complex subunit 2-like is involved in mRNA processing, the prevention of DNA replication indirectly limits the protein's ability to engage in its normal function due to a reduction in the biogenesis of mRNAs. Similarly, Actinomycin D binds tightly to DNA and blocks the progression of RNA polymerase, consequently halting RNA synthesis. This action results in a decrease in the RNA substrates that THO complex subunit 2-like would typically act upon. Alpha-amanitin specifically targets RNA polymerase II, the enzyme responsible for synthesizing mRNA, hence reducing the availability of mRNA molecules for THO complex subunit 2-like to process.

Another set of inhibitors, including Camptothecin, Etoposide, and β-Lapachone, execute their inhibitory effects by targeting enzymes involved in the transcription process. Camptothecin and Etoposide inhibit DNA topoisomerases I and II, respectively, which can result in DNA damage and a cessation of transcription elongation. This would indirectly diminish the role of THO complex subunit 2-like by curtailing the transcription of mRNAs it would normally process. β-Lapachone disrupts RNA polymerase II activity by inducing the production of reactive oxygen species, which again leads to a reduction in RNA synthesis. Other inhibitors, such as Triptolide and DrB, target transcriptional initiation and elongation. Triptolide binds to a subunit of TFIIH complex, while DrB hinders the elongation capability of RNA polymerase II. Both of these actions result in fewer nascent RNA molecules for THO complex subunit 2-like to process. Cordycepin, by being incorporated into RNA, prematurely terminates mRNA elongation, thus reducing the production of full-length mRNAs for THO complex subunit 2-like. Leptomycin B, while not directly an inhibitor of transcription or DNA replication, impedes the export of RNA molecules from the nucleus by inhibiting the nuclear export signal (NES) receptor, Crm1, which could alter the normal function of THO complex subunit 2-like in mRNA processing. Flavopiridol and Omnibetulinic acid, through inhibition of cyclin-dependent kinases and RNA polymerase III, respectively, contribute to the overall reduction in the transcriptional landscape, thereby influencing the quantity of RNA substrates available for THO complex subunit 2-like function.